Showing 117 of 117on this page. Filters & sort apply to loaded results; URL updates for sharing.117 of 117 on this page
Novartis
Novartis To Expand Heart Drug Portfolio With $1.4…
Novartis AG $NVS Shares Sold by WealthTrust Axiom LLC
Media Library | Novartis
Novartis Oncology Logo
Novartis Logo Transparent
Novartis 2025: Strengthening foundations and delivering returns ...
Novartis: Streamlining Analytics & AI Across the Organization | Dataiku
The Novartis Logo History, Colors, Font, And Meaning
Novartis Animal Pharmaceuticals
Novartis: News, Hintergründe und Analysen
Novartis Vanrafia Phase III data support slowing of kidney function ...
Project : Novartis - Big Image Group Pte Ltd
Novartis News Via Stat: Latest on the Pharmaceutical Company
Novartis AG Receives First Ever FDA Approval for CAR-T
Novartis Reports Strong Phase III Results for Remibrutinib and Moves ...
Your Novartis Benefits & Career: Financial Planning for Employees and ...
Novartis Confirms 2018 Targets as Alcon Recovery Gains Steam - Eyewire+
Παγκόσμια Ημέρα Υγείας: Η δέσμευση της Novartis για ισότιμη πρόσβαση ...
Novartis pays $12B for late-stage dystrophy biotech Avidity
Será que todo mundo terá acesso aos medicamentos da Novartis? - SWI ...
Novartis in-licenses COVID-19 treatment ensovibep from Molecular ...
Novartis kommt 2027er-Profitabilitätsziel immer näher
Novartis logo on the Banting 1 building, Novartis Campus Basel ...
Novartis: Aktuelle Entwicklungen im Überblick | Nau.ch
Novartis India shares surge most in over six years on this important ...
Novartis Profit Hurt by U.S. Settlement - WSJ
Novartis 14 İlacını Türkiye'den Çektiğini Açıkladı - İlaç Emekçileri
Novartis Stock Pops — As Travere Therapeutics Slides — On FDA Approval ...
Novartis odčlenil divíziu generických liečiv Sandoz a uviedol ju na ...
Novartis - Vikipedi
FDA aprueba Vanrafia de Novartis - Pharmabiz.NET
Novartis streicht Funktion des Schweizer Länderpräsidenten | Nau.ch
Novartis Geschäftsgeschichte , Geschichte – LNJE
Novartis mulling billion-dollar sales of ophthalmology and respiratory ...
Novartis’s big bet on sickle cell disease struggles to reach Kenya ...
Novartis plans to spin off generics division Sandoz - SWI swissinfo.ch
Novartis Pharmaceuticals
Novartis sets sights on high-value medicines and US market - SWI ...
Novartis Png Effective Q1 2024 Novartis Presentation Design
Novartis oral Fabhalta secures USFDA okay for adults with C3 glomerulopathy
Novartis CEO criticizes US, EU efforts to curb drug company power - AOL
Novartis Pivots to Aggressive Pluvicto Expansion Strategy as Growth ...
Novartis loses legal battle to block US Entresto generic until 2026
Novartis and ProFound enter cardiovascular disease collaboration worth ...
Novartis says Phase 3 data prove new antimalarial could address resistance
CDSCO Panel Approves Novartis Protocol Amendment Proposal for ...
Novartis’ Rhapsido shows promise in Phase 2 food allergy data
Novartis ends development of KRAS drug, citing 'increasing options ...
Novartis to cut 2,200 Swiss jobs by 2020 - SWI swissinfo.ch
Novartis übernimmt Tourmaline Bio für 1,4 Milliarden Dollar
US FDA approves Novartis's Ilaris for Active Still’s disease treatment ...
Pfizer pauses DMD gene therapy trial after boy’s death | pharmaphorum
Novartis to pay Monte Rosa $150 million upfront to develop a new class ...
Novartis to begin manufacturing prostate cancer treatment Pluvicto at ...
Novartis esta trabajando en propuestas de reducción de precios para ...
Novartis' BTK inhibitor wins FDA approval in chronic hives
Novartis: Últimas noticias económicas de Novartis
Novartis Logo in vector format (SVG)
Novartis Pharma Latest-SS.pptx
Logotipo Da Novartis Branco Novartis Pharma Projects :: Photos,
Novartis presents promising new data on treatment for... | CPHI Online
Novartis to Open $1 Billion Research Center in China | IndustryWeek
Novartis - Bryden pi
Novartis International Reports Double-Digit Growth in Core Operating ...
Novartis: Company Profile, Ownership & M&A Activity | Mergr
Pharma giant Novartis to cut up to 400 jobs from Dublin site
Novartis: Ως ύποπτοι κλήθηκαν στον εισαγγελέα για εξηγήσεις ...
Novartis to license cancer drug to low- and middle-income countries
Brassring Novartis India at Eric Main blog
Novartis: Έρευνα στο σπίτι του Νίκου Μανιαδάκη | Athens Voice
Novartis: Αυτά είναι τα αληθινά ονόματα των προστατευόμενων μαρτύρων ...
Novartis Exceeds Q1 Forecasts, Boosts Outlook as Blockbuster Drug Sales ...
Novartis halts US production for cancer drugs Lutathera, Pluvicto
Novartis Biome und Legit.Health arbeiten gemeinsam an digitalen ...
Novartis Pharma, Rich History, Mission and Values, and 17 Products ...
Novartis Trial Marks Researchkit First In Ms Pmlive
Novartis unveils new hybrid office as part of its Malaysian footprint ...
Novartis AG to sell entire 70.68% stake for ₹1,445.89 crore in India ...
Kymriah GMP issues in NJ led to FDA letter for Novartis
Novartis migraine drug not cost effective - U.K. price watchdog, ET ...
After delay caused by Italian CDMO, Novartis moves manufacturing to ...
Novartis dice adiós a Sandoz: Creará empresa independiente de genéricos
Novartis Expands Radioligand Therapy Portfolio with $1B Acquisition of ...
Novartis | Foro Económico Mundial
Greece prosecutes Novartis graft probe witnesses - Bilyonaryo Business News
Novartis отделя Sandoz - Economy.bg
Guia da Farmácia | Novartis anuncia novas lideranças em sua maior ...
Novartis to acquire Regulus Therapeutics and farabursen, an ...
Novartis: Ενοχή των δύο πρώην προστατευόμενων μαρτύρων, αποφάσισε το ...
Novartis planira da ukine 550 radnih mesta u Švajcarskoj do kraja 2027 ...
Novartis Novartis Hi Res Stock Photography And Images Alamy
Novartis' Pluvicto hits goal in earlier prostate cancer
Novartis AG Aktie (904278) Kurs & News - Wann sollte man kaufen ...
Novartis Has Stockpiles to Withstand Potential Trump Tariffs, CEO Says
Novartis: Lymphoma Study Shows CART On Track For 2017 US Submission
Novartis Phase III data confirm sustained efficacy and
Novartis: nuevo gte gral para Argentina - Pharmabiz.NET
Novartis AG (SWX:NOVN) Stock Price & Overview
Novartis forecasts profit gains despite copycat competition - SWI ...
Novartis готовится продать свою долю в Roche | МОСМЕДПРЕПАРАТЫ
Novartis erhöht Gewinnprognose zum zehnten Mal | Nau.ch
Novartis Aktie 2026 - NOVN - Webinvestor.io
Guia da Farmácia | Novartis oferece oportunidade de estágio na Suíça ...
Novartis приобретает разработчика в области нейробиологии - Cadent ...
Novartis Logo Png
Novartis Names Sandoz Board Members Ahead of Spin-Off
Novartis tem alta no lucro e na receita no 2º trimestre | Empresas ...
With new settlement, Novartis has shelled out $1.3B for kickbacks ...
Novartis Logo High Resolution
Novartis Biomedical Research - MassBio
Δίκη Novartis: Καταγγελίες-βόμβα από την «Αικατερίνη Κελέση» – Ποιους ...
Novartis erhöht 2025 erneut den CEO-Lohn von Vas Narasimhan | Nau.ch
:max_bytes(150000):strip_icc()/GettyImages-1451737630-675fde06632049f68ccca63df9d8c94b.jpg)
:max_bytes(150000):strip_icc()/GettyImages-1244662972-6c92522b2e9d48ada3788062940cec51.jpg)
:strip_icc()/i.s3.glbimg.com/v1/AUTH_63b422c2caee4269b8b34177e8876b93/internal_photos/bs/2019/e/j/zIWn0JTPABz1cBtZEmBA/025out10.jpg)
